Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor

Clinical Cancer Research

Volumn 17, Issue 19, 2011, Pages 6185-6191

  Bartucci, Monica ^a   Dattilo, Rosanna ^a   Martinetti, Daniela ^b   Todaro, Matilde ^c   Zapparelli, Giuseppina ^a   Di Virgilio, Antonio ^a   Biffoni, Mauro ^a   De Maria, Ruggero ^a   Zeuner, Ann ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Istituto Oncologico del Mediterraneo   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; RECOMBINANT STEM CELL FACTOR;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED ANEMIA; CHEMOTHERAPY INDUCED THROMBOCYTOPENIA; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; ENZYME ACTIVATION; ERYTHROID CELL; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TISSUE PRESERVATION; TREATMENT DURATION;

ANEMIA; ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; ERYTHROID PRECURSOR CELLS; FEMALE; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; STEM CELL FACTOR; THROMBOCYTOPENIA;

EID: 80053531119     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-1232     Document Type: Article

References (18)

1. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997;90:1345-64. (Pubitemid 27355406)
2. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, et al. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213-24.
3. Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, et al. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990;63:225-33.
4. Copeland NG, Gilbert DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, et al. Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990;63:175-83.
5. Perry JM, Harandi OF, Paulson RF. BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. Blood 2007;109:4494-502. (Pubitemid 46743420)
6. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988;335:88-9.
7. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988;55:185-92.
8. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 1991;78:961-6.
9. Andrews RG, Knitter GH, Bartelmez SH, Langley KE, Farrar D, Hendren RW, et al. Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 1991;78:1975-80.
10. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, et al. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 1993;82:784-91. (Pubitemid 23221656)
11. Blaise D, Faucher C, Vey N, Caraux J, Maraninchi D, Chabannon C. Rescue of haemopoiesis by a combination of growth factors including stem-cell factor. Lancet 2000;356:1325-6.
12. Sui X, Krantz SB, Zhao ZJ. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol 2000;110:63-70. (Pubitemid 30627496)
13. + human primary erythroid cells from apoptosis. Exp Hematol 2001;29:833-41.
14. Zeuner A, Pedini F, Signore M, Testa U, Pelosi E, Peschle C, et al. Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins. Blood 2003;102:87-93. (Pubitemid 36759640)
15. Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, De Maria R, et al. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 2007;67:4767-73. (Pubitemid 46910184)
16. Hunt P, Zsebo KM, Hokom MM, Hornkohl A, Birkett NC, Del Castillo JC, et al. Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-fluorouracil treatment. Blood 1992;80:904-11.
17. Lynch DH, Jacobs C, DuPont D, Eisenman J, Foxworthe D, Martin U, et al. Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF). Lymphokine Cytokine Res 1992;11:233-43.
18. Boxio R, Bossenmeyer-Pourie C, Steinckwich N, Dournon C, Nusse O. Mouse bone marrow contains large numbers of functionally competent neutrophils. J Leukoc Biol 2004;75:604-11. (Pubitemid 38405651)